Drug intelligence / Profile preview

Nodoryl Complex

Development stage
Unknown
Lead developer
Meditop Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Nodoryl Complex is an over-the-counter (OTC) fixed-dose combination analgesic developed and marketed by Meditop Pharmaceutical in Hungary. It contains three active ingredients: metamizole sodium monohydrate (a non-opioid analgesic and antipyretic), caffeine (a central nervous system stimulant that enhances analgesic efficacy), and drotaverine hydrochloride (an antispasmodic agent). The product is specifically indicated for the treatment of severe headaches, headaches refractory to other treatments, and the initial phase of mild to moderate migraine attacks. It is available in two tablet strengths (200/30/20 mg and 400/60/40 mg) and works through a multi-modal mechanism that addresses both pain perception and vascular/smooth muscle spasms associated with headaches.

Brand names
Nodoryl Complex
02

Targets

ADORA1 (Adenosine receptor A1 subtype)ADORA2A (Adenosine A₂A Receptor)LTCC (Voltage-gated calcium channel (L-type))PDE4APGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PDE4 (Phosphodiesterase 4A1)

Beyond the preview

Go deeper on Nodoryl Complex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nodoryl Complex.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call